Ayala Pharmaceuticals Inc (ADXS)

[equaloppforall]

But not all phase 3 companies have an SPA from the FDA and ATMP from the EMA for their lead product. Not all companies have the best ever phase 2 data, reported by an independent agency, for said product. Besides, nobody is saying that ADXS deserves to "roll in money" based on these facts, just that it doesn't deserve to go down to the $3 range, as your original post suggested.

I brought up the number of people reading the board as a cautionary point, to consider minimizing exaggerations and compromising one's credibility, not because it impacts the PPS in any way.